DKSH Business Unit Healthcare, a market expansion services company in Asia, will provide regulatory, distribution and logistics services for Actelion in Hong Kong, Malaysia and Singapore. Actelion, a biopharmaceutical company based in Basel, Switzerland has a portfolio of PAH treatments, as well as treatments for diseases including Type 1 Gaucher disease, Niemann-Pick type C disease, digital ulcers in patients suffering from systemic sclerosis, and mycosis fungoides type cutaneous T-cell lymphom...